Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Ropanicant Phase-2b trial for Major Depressive Disorder achieves 100 percent enrollment ahead of schedule: Suven Life Sciences

Sage Therapeutics' Experimental Drug for Huntington's Disease Fails Mid-Stage Trial

Farhat Nasim21 Nov 2024 11:30 AM IST

The drug, dalzanemdor, did not significantly improve cognitive function in patients compared to placebo after 84 days, failing to meet the main goal

NPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP Uniformity

NPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details

Farhat Nasim20 Nov 2024 4:08 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for six drug formulations following review orders...

Lupin secures SBTi validation for emission reduction targets

Lupin's generic drug to treat ADHD symptoms gets USFDA approval

Farhat Nasim20 Nov 2024 2:57 PM IST

Mumbai: Lupin Limited announced on Tuesday that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its...

Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal

Merck's Injectable Keytruda Proves Effective in Trial, Promises Easier Cancer Treatment

Farhat Nasim20 Nov 2024 2:01 PM IST

Merck was testing the injectable version of the world's biggest selling drug in a late stage trial of patients with a type of lung cancer.

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

USFDA Inspection: Dr Reddy's gets Form 483 with 7 observations for Bollaram facility

Farhat Nasim20 Nov 2024 1:48 PM IST

New Delhi: Dr Reddy's Laboratories Ltd on Tuesday said the US health regulator has issued a Form 483 with seven observations to its active...

Novo Nordisks Wegovy Gets UK Nod for Higher 7.2 mg Weekly Dose in Obesity Treatment

Novo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients

Farhat Nasim20 Nov 2024 1:36 PM IST

The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has yet to launch it.

Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus Deal

Eli Lilly's Experimental Drug Muvalaplin Lowers Inherited Cholesterol by Up to 86 percent

Farhat Nasim20 Nov 2024 1:05 PM IST

Ruth Gimeno, Lilly's group vice president for diabetes and metabolic research, said Eli Lilly is weighing next steps for advancing to late stage...

Lupin unveils Risperidone Long Acting Injectable in US

Lupin launches generic equivalent of Bumex Injection in US

Farhat Nasim20 Nov 2024 12:43 PM IST

Mumbai: Global pharma major Lupin Limited (Lupin) announced on Tuesday the launch of Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose...

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood

Indian Pharma Market grows at 6.8 percent in October, Chronic Therapies Dominate: IQVIA

Farhat Nasim19 Nov 2024 6:19 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) experienced a significant 6.8% increase in Total Sales Audit (TSA) over the 12-month period ending...

CDSCO Panel Seeks Revised Phase IV Study for Zydus Empagliflozin, Metformin FDC

Delhi HC Grants Relief to Zydus in BIOCHEM Trademark Dispute

Farhat Nasim18 Nov 2024 3:28 PM IST

New Delhi: In relief to Zydus Healthcare, the Delhi High Court has granted an injunction restraining Alder Biochem Pvt. Ltd. from using the trademark...

Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical Negligence

Zydus barred from selling cancer drug Sigrima as Delhi HC restores injunction in favour of Roche

Farhat Nasim16 Nov 2024 3:25 PM IST

New Delhi: Upholding the patent rights of Swiss pharmaceutical giant F-Hoffmann-La Roche AG, the Delhi High Court has once again reinstated an...

Over 4000 medical device manufacturing sites licensed since 2021, Minister tells Parliament

DoP Releases Rs 500 Crore Operational Guidelines for Strengthening of Medical Device Industry Scheme

Farhat Nasim15 Nov 2024 5:54 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has released the operational guidelines for the newly launched Strengthening of Medical Device...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok